EpiVax Therapeutics, Inc.

New Filing
CIK: 0001724741·Biotechnology·DELAWARE·Filed: Feb 22, 2021
Total Offering

$3,000,000

Amount Sold

$425,000

Investors

6

First Sale

Aug 7, 2020

Offering Details

Type
Equity, Debt, Option to Acquire, Security to be Acquired
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2017
Non-Accredited Investors
No

Related Persons

NameRole
Anne De Groot
Related Person
William Martin
Related Person
Clifford Grimm
Related Person
Daniel Adams
Related Person
Richard Lipkin
Related Person

Company

EpiVax Therapeutics, Inc.

188 Valley Street

PROVIDENCE, RI, 02909

(401) 272-2123

SEC Filing

0001724741-21-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
EpiVax Therapeutics, Inc. Form D Filing — $3,000,000 | FilingFlow